Malaria (original) (raw)

• Miller, L. H., Ackerman, H. C., Su, X. Z. & Wellems, T. E. Malaria biology and disease pathogenesis: insights for new treatments. Nat. Med. 19, 156–167 (2013).
  CAS PubMed PubMed Central Google Scholar
• White, N. J. et al. Malaria. Lancet 383, 723–735 (2014).
  PubMed Google Scholar
• Cowman, A. F., Healer, J., Marapana, D. & Marsh, K. Malaria: biology and disease. Cell 167, 610–624 (2016). References 1–3 comprehensively review malaria biology and the disease.
  CAS PubMed Google Scholar
• Baker, D. A. Malaria gametocytogenesis. Mol. Biochem. Parasitol. 172, 57–65 (2010).
  CAS PubMed PubMed Central Google Scholar
• Waters, A. P. Epigenetic roulette in blood stream Plasmodium: gambling on sex. PLoS Pathog. 12, e1005353 (2016).
  PubMed PubMed Central Google Scholar
• White, N. J. Determinants of relapse periodicity in Plasmodium vivax malaria. Malar. J. 10, 297 (2011).
  PubMed PubMed Central Google Scholar
• Wassmer, S. C. et al. Investigating the pathogenesis of severe malaria: a multidisciplinary and cross-geographical approach. Am. J. Trop. Med. Hyg. 93, 42–56 (2015). Comprehensively reviews the causes of severe malaria and ongoing research efforts to understand malaria pathophysiology.
  CAS PubMed PubMed Central Google Scholar
• Wassmer, S. C. & Grau, G. E. Severe malaria: what's new on the pathogenesis front? Int. J. Parasitol. 47, 145–152 (2017).
  PubMed Google Scholar
• World Health Organization. Severe malaria. Trop. Med. Int. Health 19 (Suppl. 1), 7–131 (2014).
  Google Scholar
• Dondorp, A. M. & Day, N. P. The treatment of severe malaria. Trans. R. Soc. Trop. Med. Hyg. 101, 633–634 (2007).
  PubMed Google Scholar
• Bernabeu, M. & Smith, J. D. EPCR and malaria severity: the center of a perfect storm. Trends Parasitol. 33, 295–308 (2017). Reviews the molecular basis of parasite sequestration in the tissues, which leads to the obstruction of the microvasculature and severe disease, and discusses the key role of EPCR in these processes.
  PubMed Google Scholar
• Bhatt, S. et al. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature 526, 207–211 (2015). Attempts to identify the relative contribution of different antimalaria measures in reducing the number of malaria cases over the 2000–2015 period.
  CAS PubMed PubMed Central Google Scholar
• Mitchell, S. N. et al. Mosquito biology. Evolution of sexual traits influencing vectorial capacity in anopheline mosquitoes. Science 347, 985–988 (2015).
  CAS PubMed PubMed Central Google Scholar
• Sinka, M. E. et al. The dominant Anopheles vectors of human malaria in Africa, Europe and the Middle East: occurrence data, distribution maps and bionomic precis. Parasit. Vectors 3, 117 (2010).
  PubMed PubMed Central Google Scholar
• World Health Organization. Eliminating malaria: learning from the past, looking ahead. WHOhttp://www.path.org/publications/files/MCP_rbm_pi_rpt_8.pdf (2011).
• World Health Organization. World malaria report 2015. WHOhttp://www.who.int/malaria/publications/world-malaria-report-2015/report/en/ (2015).
• Florens, L. et al. A proteomic view of the Plasmodium falciparum life cycle. Nature 419, 520–526 (2002).
  CAS PubMed Google Scholar
• Gardner, M. J. et al. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 419, 498–511 (2002). Reports for the first time the P. falciparum genome, which has formed the basis for research into the molecular basis of pathogenesis and parasite biology; a modern-day understanding of the disease would not be possible without this groundbreaking work.
  CAS PubMed Google Scholar
• Winzeler, E. A. Advances in parasite genomics: from sequences to regulatory networks. PLoS Pathog. 5, e1000649 (2009).
  PubMed PubMed Central Google Scholar
• Gething, P. W. et al. Mapping Plasmodium falciparum mortality in Africa between 1990 and 2015. N. Engl. J. Med. 375, 2435–2445 (2016).
  PubMed PubMed Central Google Scholar
• Maitland, K. Severe malaria in African children — the need for continuing investment. N. Engl. J. Med. 375, 2416–2417 (2016).
  PubMed PubMed Central Google Scholar
• Miller, L. H., Mason, S. J., Clyde, D. F. & McGinniss, M. H. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N. Engl. J. Med. 295, 302–304 (1976). Describes the discovery that led to a molecular understanding of why most Africans are resistant to infection by P. vivax, thereby explaining the limited penetration of P. vivax in Africa.
  CAS PubMed Google Scholar
• Mercereau-Puijalon, O. & Menard, D. Plasmodium vivax and the Duffy antigen: a paradigm revisited. Transfus. Clin. Biol. 17, 176–183 (2010).
  CAS PubMed Google Scholar
• Howes, R. E. et al. Plasmodium vivax transmission in Africa. PLoS Negl. Trop. Dis. 9, e0004222 (2015).
  PubMed PubMed Central Google Scholar
• Sutherland, C. J. et al. Two nonrecombining sympatric forms of the human malaria parasite Plasmodium ovale occur globally. J. Infect. Dis. 201, 1544–1550 (2010).
  CAS PubMed Google Scholar
• Cox-Singh, J. et al. Plasmodium knowlesi malaria in humans is widely distributed and potentially life threatening. Clin. Infect. Dis. 46, 165–171 (2008).
  CAS PubMed Google Scholar
• Singh, B. et al. A large focus of naturally acquired Plasmodium knowlesi infections in human beings. Lancet 363, 1017–1024 (2004). Describes the discovery that P. knowlesi, which was previously thought to primarily infect macaques, accounted for over half of the cases of malaria in their study in the Kapit district (Malaysia). Demonstrates for the first time that P. knowlesi should be considered as an emerging infectious disease in humans. Whether transmission via mosquitoes was occurring from monkey to man or from man to man remained an open question.
  PubMed Google Scholar
• Brock, P. M. et al. Plasmodium knowlesi transmission: integrating quantitative approaches from epidemiology and ecology to understand malaria as a zoonosis. Parasitology 143, 389–400 (2016).
  CAS PubMed Google Scholar
• Imwong, M., Nakeesathit, S., Day, N. P. & White, N. J. A review of mixed malaria species infections in anopheline mosquitoes. Malar. J. 10, 253 (2011).
  PubMed PubMed Central Google Scholar
• Ginouves, M. et al. Frequency and distribution of mixed Plasmodium falciparum_–_vivax infections in French Guiana between 2000 and 2008. Malar. J. 14, 446 (2015).
  PubMed PubMed Central Google Scholar
• Srisutham, S. et al. Four human Plasmodium species quantification using droplet digital PCR. PLoS ONE 12, e0175771 (2017).
  PubMed PubMed Central Google Scholar
• Armed Forces Health Surveillance Branch. Update: malaria, U. S. Armed Forces, 2016. MSMR 24, 2–7 (2017).
  Google Scholar
• IISS: International Institute for Strategic Studies. Armed Conflict Survey 2016 (IISS, 2016).
• Mueller, I. et al. Natural acquisition of immunity to Plasmodium vivax: epidemiological observations and potential targets. Adv. Parasitol. 81, 77–131 (2013).
  PubMed Google Scholar
• Ataide, R., Mayor, A. & Rogerson, S. J. Malaria, primigravidae, and antibodies: knowledge gained and future perspectives. Trends Parasitol. 30, 85–94 (2014).
  PubMed Google Scholar
• Desai, M. et al. Epidemiology and burden of malaria in pregnancy. Lancet Infect. Dis. 7, 93–104 (2007).
  PubMed Google Scholar
• McGready, R. et al. Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study. Lancet Infect. Dis. 12, 388–396 (2012).
  CAS PubMed PubMed Central Google Scholar
• Cohen, C. et al. Increased prevalence of severe malaria in HIV-infected adults in South Africa. Clin. Infect. Dis. 41, 1631–1637 (2005).
  PubMed Google Scholar
• Mulu, A. et al. Epidemiological and clinical correlates of malaria–helminth co-infections in southern Ethiopia. Malar. J. 12, 227 (2013).
  PubMed PubMed Central Google Scholar
• Gwamaka, M. et al. Iron deficiency protects against severe Plasmodium falciparum malaria and death in young children. Clin. Infect. Dis. 54, 1137–1144 (2012).
  CAS PubMed PubMed Central Google Scholar
• Neuberger, A., Okebe, J., Yahav, D. & Paul, M. Oral iron supplements for children in malaria-endemic areas. Cochrane Database Syst. Rev. 2, CD006589 (2016).
  PubMed Google Scholar
• Tilley, L., Straimer, J., Gnadig, N. F., Ralph, S. A. & Fidock, D. A. Artemisinin action and resistance in Plasmodium falciparum . Trends Parasitol. 32, 682–696 (2016). Comprehensively reviews the emerging threat of artemisinin resistance, covering what is known about the mechanism of action of the drug and the molecular basis of artemisinin resistance.
  CAS PubMed PubMed Central Google Scholar
• Woodrow, C. J. & White, N. J. The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread. FEMS Microbiol. Rev. 41, 34–48 (2017).
  CAS PubMed PubMed Central Google Scholar
• Menard, D. et al. A worldwide map of Plasmodium falciparum K13-propeller polymorphisms. N. Engl. J. Med. 374, 2453–2464 (2016).
  PubMed PubMed Central Google Scholar
• Imwong, M. et al. The spread of artemisinin-resistant Plasmodium falciparum in the greater Mekong subregion: a molecular epidemiology observational study. Lancet Infect. Dis. 17, 491–497 (2017).
  PubMed PubMed Central Google Scholar
• Paul, A. S., Egan, E. S. & Duraisingh, M. T. Host–parasite interactions that guide red blood cell invasion by malaria parasites. Curr. Opin. Hematol. 22, 220–226 (2015). Reviews the molecular basis of parasite invasion.
  CAS PubMed PubMed Central Google Scholar
• Lim, C. et al. Reticulocyte preference and stage development of Plasmodium vivax isolates. J. Infect. Dis. 214, 1081–1084 (2016).
  PubMed PubMed Central Google Scholar
• Boddey, J. A. & Cowman, A. F. Plasmodium nesting: remaking the erythrocyte from the inside out. Annu. Rev. Microbiol. 67, 243–269 (2013).
  CAS PubMed Google Scholar
• Spillman, N. J., Beck, J. R. & Goldberg, D. E. Protein export into malaria parasite-infected erythrocytes: mechanisms and functional consequences. Annu. Rev. Biochem. 84, 813–841 (2015). Reviews the biology associated with red blood cell remodelling upon parasite invasion.
  CAS PubMed Google Scholar
• Phillips, M. A. in Neglected Diseases and Drug Discovery (eds Palmer, M. & Wells, T. N. C. ) 65–87 (RCS Publishing, 2011).
  Google Scholar
• Istvan, E. S. et al. Validation of isoleucine utilization targets in Plasmodium falciparum . Proc. Natl Acad. Sci. USA 108, 1627–1632 (2011).
  CAS PubMed PubMed Central Google Scholar
• Wunderlich, J., Rohrbach, P. & Dalton, J. P. The malaria digestive vacuole. Front. Biosci. (Schol. Ed.) 4, 1424–1448 (2012).
  Google Scholar
• Chugh, M. et al. Protein complex directs hemoglobin-to-hemozoin formation in Plasmodium falciparum . Proc. Natl Acad. Sci. USA 110, 5392–5397 (2013).
  CAS PubMed PubMed Central Google Scholar
• Sigala, P. A. & Goldberg, D. E. The peculiarities and paradoxes of Plasmodium heme metabolism. Annu. Rev. Microbiol. 68, 259–278 (2014).
  CAS PubMed Google Scholar
• Spillman, N. J. et al. Na+ regulation in the malaria parasite Plasmodium falciparum involves the cation ATPase PfATP4 and is a target of the spiroindolone antimalarials. Cell Host Microbe 13, 227–237 (2013). Identifies the protein target of one of the key new antimalarials that is in clinical development.
  CAS PubMed PubMed Central Google Scholar
• Spillman, N. J. & Kirk, K. The malaria parasite cation ATPase PfATP4 and its role in the mechanism of action of a new arsenal of antimalarial drugs. Int. J. Parasitol. Drugs Drug Resist. 5, 149–162 (2015).
  PubMed PubMed Central Google Scholar
• Jimenez-Diaz, M. B. et al. (+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of Plasmodium. Proc. Natl Acad. Sci. USA 111, E5455–E5462 (2014).
  CAS PubMed PubMed Central Google Scholar
• McNamara, C. W. et al. Targeting Plasmodium PI(4)K to eliminate malaria. Nature 504, 248–253 (2013). Identifies an important new target for drug discovery.
  CAS PubMed PubMed Central Google Scholar
• Rosenberg, R., Wirtz, R. A., Schneider, I. & Burge, R. An estimation of the number of malaria sporozoites ejected by a feeding mosquito. Trans. R. Soc. Trop. Med. Hyg. 84, 209–212 (1990).
  CAS PubMed Google Scholar
• Sinnis, P. & Zavala, F. The skin: where malaria infection and the host immune response begin. Semin. Immunopathol. 34, 787–792 (2012).
  CAS PubMed PubMed Central Google Scholar
• Frischknecht, F. et al. Imaging movement of malaria parasites during transmission by Anopheles mosquitoes. Cell. Microbiol. 6, 687–694 (2004).
  CAS PubMed Google Scholar
• Zheng, H., Tan, Z. & Xu, W. Immune evasion strategies of pre-erythrocytic malaria parasites. Mediators Inflamm. 2014, 362605 (2014).
  PubMed PubMed Central Google Scholar
• Duraisingh, M. T. & Horn, D. Epigenetic regulation of virulence gene expression in parasitic protozoa. Cell Host Microbe 19, 629–640 (2016).
  CAS PubMed PubMed Central Google Scholar
• Smith, J. D. The role of PfEMP1 adhesion domain classification in Plasmodium falciparum pathogenesis research. Mol. Biochem. Parasitol. 195, 82–87 (2014).
  CAS PubMed PubMed Central Google Scholar
• Dobbs, K. R. & Dent, A. E. Plasmodium malaria and antimalarial antibodies in the first year of life. Parasitology 143, 129–138 (2016).
  PubMed Google Scholar
• Fowkes, F. J., Boeuf, P. & Beeson, J. G. Immunity to malaria in an era of declining malaria transmission. Parasitology 143, 139–153 (2016).
  PubMed Google Scholar
• Teo, A., Feng, G., Brown, G. V., Beeson, J. G. & Rogerson, S. J. Functional antibodies and protection against blood-stage malaria. Trends Parasitol. 32, 887–898 (2016).
  CAS PubMed Google Scholar
• Marsh, K. & Kinyanjui, S. Immune effector mechanisms in malaria. Parasite Immunol. 28, 51–60 (2006).
  CAS PubMed Google Scholar
• Parroche, P. et al. Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9. Proc. Natl Acad. Sci. USA 104, 1919–1924 (2007).
  CAS PubMed PubMed Central Google Scholar
• Karunaweera, N. D., Grau, G. E., Gamage, P., Carter, R. & Mendis, K. N. Dynamics of fever and serum levels of tumor necrosis factor are closely associated during clinical paroxysms in Plasmodium vivax malaria. Proc. Natl Acad. Sci. USA 89, 3200–3203 (1992).
  CAS PubMed PubMed Central Google Scholar
• Vijaykumar, M., Naik, R. S. & Gowda, D. C. Plasmodium falciparum glycosylphosphatidylinositol-induced TNF-α secretion by macrophages is mediated without membrane insertion or endocytosis. J. Biol. Chem. 276, 6909–6912 (2001).
  CAS PubMed Google Scholar
• Wijesekera, S. K., Carter, R., Rathnayaka, L. & Mendis, K. N. A malaria parasite toxin associated with Plasmodium vivax paroxysms. Clin. Exp. Immunol. 104, 221–227 (1996).
  CAS PubMed PubMed Central Google Scholar
• Hosseini, S. M. & Feng, J. J. How malaria parasites reduce the deformability of infected red blood cells. Biophys. J. 103, 1–10 (2012).
  CAS PubMed PubMed Central Google Scholar
• Gillrie M. R. et al. Thrombin cleavage of Plasmodium falciparum erythrocyte membrane protein 1 inhibits cytoadherence. mBio 7 e01120-16 (2016).
  PubMed PubMed Central Google Scholar
• Bernabeu, M. et al. Severe adult malaria is associated with specific PfEMP1 adhesion types and high parasite biomass. Proc. Natl Acad. Sci. USA 113, E3270–E3279 (2016).
  CAS PubMed PubMed Central Google Scholar
• Fox, L. L. et al. Histidine-rich protein 2 plasma levels predict progression to cerebral malaria in Malawian children with Plasmodium falciparum infection. J. Infect. Dis. 208, 500–503 (2013).
  CAS PubMed PubMed Central Google Scholar
• Seydel, K. B. et al. Brain swelling and death in children with cerebral malaria. N. Engl. J. Med. 372, 1126–1137 (2015).
  CAS PubMed PubMed Central Google Scholar
• Lopez, C., Saravia, C., Gomez, A., Hoebeke, J. & Patarroyo, M. A. Mechanisms of genetically-based resistance to malaria. Gene 467, 1–12 (2010).
  CAS PubMed Google Scholar
• Piel, F. B. The present and future global burden of the inherited disorders of hemoglobin. Hematol. Oncol. Clin. North Am. 30, 327–341 (2016).
  PubMed Google Scholar
• Elguero, E. et al. Malaria continues to select for sickle cell trait in Central Africa. Proc. Natl Acad. Sci. USA 112, 7051–7054 (2015).
  CAS PubMed PubMed Central Google Scholar
• Kwiatkowski, D. P. How malaria has affected the human genome and what human genetics can teach us about malaria. Am. J. Hum. Genet. 77, 171–192 (2005).
  CAS PubMed PubMed Central Google Scholar
• Cheng, Y. et al. Plasmodium vivax GPI-anchored micronemal antigen (PvGAMA) binds human erythrocytes independent of Duffy antigen status. Sci. Rep. 6, 35581 (2016).
  CAS PubMed PubMed Central Google Scholar
• Gunalan, K. et al. Role of Plasmodium vivax Duffy-binding protein 1 in invasion of Duffy-null Africans. Proc. Natl Acad. Sci. USA 113, 6271–6276 (2016).
  CAS PubMed PubMed Central Google Scholar
• Guindo, A., Fairhurst, R. M., Doumbo, O. K., Wellems, T. E. & Diallo, D. A. X-Linked G6PD deficiency protects hemizygous males but not heterozygous females against severe malaria. PLoS Med. 4, e66 (2007).
  PubMed PubMed Central Google Scholar
• Cholera, R. et al. Impaired cytoadherence of _Plasmodium falciparum_-infected erythrocytes containing sickle hemoglobin. Proc. Natl Acad. Sci. USA 105, 991–996 (2008).
  CAS PubMed PubMed Central Google Scholar
• Fairhurst, R. M. et al. Abnormal display of PfEMP-1 on erythrocytes carrying haemoglobin C may protect against malaria. Nature 435, 1117–1121 (2005). References 84 and 86 identify key genetic traits that are associated with protection against P. falciparum malaria.
  CAS PubMed Google Scholar
• World Health Organization. Malaria: diagnostic testing. WHOhttp://www.who.int/malaria/areas/diagnosis/en/ (2016).
• Worldwide Antimalarial Resistance Network (WWARN) AL Dose Impact Study Group. The effect of dose on the antimalarial efficacy of artemether–lumefantrine: a systematic review and pooled analysis of individual patient data. Lancet Infect. Dis. 15, 692–702 (2015). Describes data from the Worldwide Antimalarial Resistance Network (WWARN), which has set up computational tools that measure parasite reduction from human data; the WWARN also collects information on emerging resistance.
  Google Scholar
• Joanny, F., Lohr, S. J., Engleitner, T., Lell, B. & Mordmuller, B. Limit of blank and limit of detection of Plasmodium falciparum thick blood smear microscopy in a routine setting in Central Africa. Malar. J. 13, 234 (2014).
  PubMed PubMed Central Google Scholar
• Azikiwe, C. C. et al. A comparative laboratory diagnosis of malaria: microscopy versus rapid diagnostic test kits. Asian Pac. J. Trop. Biomed. 2, 307–310 (2012).
  CAS PubMed PubMed Central Google Scholar
• McCarthy, J. S. et al. A pilot randomised trial of induced blood-stage Plasmodium falciparum infections in healthy volunteers for testing efficacy of new antimalarial drugs. PLoS ONE 6, e21914 (2011). Describes the use of the human blood-stage challenge model for drug testing. This model has gone on to be an important tool for the early evaluation of the clinical efficacy of new antimalarial compounds.
  CAS PubMed PubMed Central Google Scholar
• Phiri, K. et al. Parasitological clearance rates and drug concentrations of a fixed dose combination of azithromycin–chloroquine in asymptomatic pregnant women with Plasmodium Falciparum parasitemia: an open-label, non-comparative study in sub-Saharan Africa. PLoS ONE 11, e0165692 (2016).
  PubMed PubMed Central Google Scholar
• Imwong, M. et al. Numerical distributions of parasite densities during asymptomatic malaria. J. Infect. Dis. 213, 1322–1329 (2016).
  CAS PubMed Google Scholar
• Notomi, T. et al. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res. 28, E63 (2000).
  CAS PubMed PubMed Central Google Scholar
• Sema, M. et al. Evaluation of non-instrumented nucleic acid amplification by loop-mediated isothermal amplification (NINA-LAMP) for the diagnosis of malaria in northwest Ethiopia. Malar. J. 14, 44 (2015).
  PubMed PubMed Central Google Scholar
• Pholwat, S. et al. The malaria TaqMan array card includes 87 assays for Plasmodium falciparum drug resistance, identification of species, and genotyping in a single reaction. Antimicrob. Agents Chemother. 61 e00110-17 (2017).
  PubMed PubMed Central Google Scholar
• Foundation for Innovative New Diagnostics. Acute febrile syndrome strategy. FiNDhttp://r4d.dfid.gov.uk/PDF/Outputs/FIND/0031-FIND-NMFI-document-print-inhouse.pdf (2012).
• Gamboa, D. et al. A large proportion of P. falciparum isolates in the Amazon region of Peru lack pfhrp2 and pfhrp3: implications for malaria rapid diagnostic tests. PLoS ONE 5, e8091 (2010).
  PubMed PubMed Central Google Scholar
• Akinyi, S. et al. Multiple genetic origins of histidine-rich protein 2 gene deletion in Plasmodium falciparum parasites from Peru. Sci. Rep. 3, 2797 (2013).
  PubMed PubMed Central Google Scholar
• Cheng, Q. et al. Plasmodium falciparum parasites lacking histidine-rich protein 2 and 3: a review and recommendations for accurate reporting. Malar. J. 13, 283 (2014).
  PubMed PubMed Central Google Scholar
• Bharti, P. K. et al. Prevalence of pfhrp2 and/or pfhrp3 gene deletion in Plasmodium falciparum population in eight highly endemic states in India. PLoS ONE 11, e0157949 (2016).
  PubMed PubMed Central Google Scholar
• Deme, A. B. et al. Analysis of pfhrp2 genetic diversity in Senegal and implications for use of rapid diagnostic tests. Malar. J. 13, 34 (2014).
  PubMed PubMed Central Google Scholar
• Parr, J. B. et al. Estimation of Plasmodium falciparum transmission intensity in Lilongwe, Malawi, by microscopy, rapid diagnostic testing, and nucleic acid detection. Am. J. Trop. Med. Hyg. 95, 373–377 (2016).
  CAS PubMed PubMed Central Google Scholar
• Mouatcho, J. C. & Goldring, J. P. Malaria rapid diagnostic tests: challenges and prospects. J. Med. Microbiol. 62, 1491–1505 (2013).
  CAS PubMed Google Scholar
• Soti, D. O. et al. Feasibility of an innovative electronic mobile system to assist health workers to collect accurate, complete and timely data in a malaria control programme in a remote setting in Kenya. Malar. J. 14, 430 (2015).
  PubMed PubMed Central Google Scholar
• Scherr, T. F., Gupta, S., Wright, D. W. & Haselton, F. R. Mobile phone imaging and cloud-based analysis for standardized malaria detection and reporting. Sci. Rep. 6, 28645 (2016).
  CAS PubMed PubMed Central Google Scholar
• Ouédraogo, A. L. et al. Efficacy and safety of the mosquitocidal drug ivermectin to prevent malaria transmission after treatment: a double-blind, randomized, clinical trial. Clin. Infect. Dis. 60, 357–365 (2015).
  PubMed Google Scholar
• World Health Organization. Guidelines for the treatment of malaria, 3rd edn. WHOhttp://apps.who.int/iris/bitstream/10665/162441/1/9789241549127_eng.pdf (2015).
• Chanda, E., Remijo, C. D., Pasquale, H., Baba, S. P. & Lako, R. L. Scale-up of a programme for malaria vector control using long-lasting insecticide-treated nets: lessons from South Sudan. Bull. World Health Organ. 92, 290–296 (2014).
  PubMed Google Scholar
• Ojuka, P. et al. Early biting and insecticide resistance in the malaria vector Anopheles might compromise the effectiveness of vector control intervention in southwestern Uganda. Malar. J. 14, 148 (2015).
  PubMed PubMed Central Google Scholar
• Hemingway, J. et al. Averting a malaria disaster: will insecticide resistance derail malaria control? Lancet 387, 1785–1788 (2016). Discusses key issues relating to the continued control of the mosquito that transmits malaria.
  PubMed PubMed Central Google Scholar
• Knapp, J., Macdonald, M., Malone, D., Hamon, N. & Richardson, J. H. Disruptive technology for vector control: the Innovative Vector Control Consortium and the US Military join forces to explore transformative insecticide application technology for mosquito control programmes. Malar. J. 14, 371 (2015).
  PubMed PubMed Central Google Scholar
• Sibanda, M. & Focke, W. Development of an insecticide impregnated polymer wall lining for malaria vector control. Malar. J. 13 (Suppl. 1), 80 (2014).
  Google Scholar
• Kruger, T., Sibanda, M. M., Focke, W. W., Bornman, M. S. & de Jager, C. Acceptability and effectiveness of a monofilament, polyethylene insecticide-treated wall lining for malaria control after six months in dwellings in Vhembe District, Limpopo Province, South Africa. Malar. J. 14, 485 (2015).
  PubMed PubMed Central Google Scholar
• Burt, A. Heritable strategies for controlling insect vectors of disease. Phil. Trans. R. Soc. B 369, 20130432 (2014).
  PubMed PubMed Central Google Scholar
• Committee on Gene Drive Research in Non-Human Organisms. Recommendations for Responsible Conduct. Gene Drives on the Horizon: Advancing Science, Navigating Uncertainty and Aligning Research with Public Values (National Academies Press, 2016).
• Oliva, C. F. et al. Current status and future challenges for controlling malaria with the sterile insect technique: technical and social perspectives. Acta Trop. 132, S130–S139 (2014).
  PubMed Google Scholar
• Bourtzis, K., Lees, R. S., Hendrichs, J. & Vreysen, M. J. More than one rabbit out of the hat: radiation, transgenic and symbiont-based approaches for sustainable management of mosquito and tsetse fly populations. Acta Trop. 157, 115–130 (2016).
  PubMed Google Scholar
• Black, W. C. 4th, Alphey, L. & James, A. A. Why RIDL is not SIT. Trends Parasitol. 27, 362–370 (2011).
  PubMed Google Scholar
• Windbichler, N. et al. A synthetic homing endonuclease-based gene drive system in the human malaria mosquito. Nature 473, 212–215 (2011).
  CAS PubMed PubMed Central Google Scholar
• Esvelt, K. M., Smidler, A. L., Catteruccia, F. & Church, G. M. Concerning RNA-guided gene drives for the alteration of wild populations. eLife 3, e03401 (2014).
  PubMed PubMed Central Google Scholar
• Hammond, A. et al. A CRISPR–Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae . Nat. Biotechnol. 34, 78–83 (2016).
  CAS PubMed Google Scholar
• Gantz, V. M. et al. Highly efficient Cas9-mediated gene drive for population modification of the malaria vector mosquito Anopheles stephensi . Proc. Natl Acad. Sci. USA 112, E6736–E6743 (2015).
  CAS PubMed PubMed Central Google Scholar
• Bull, J. J. & Turelli, M. Wolbachia versus dengue: evolutionary forecasts. Evol. Med. Public Health 2013, 197–207 (2013).
  PubMed PubMed Central Google Scholar
• Wilke, A. B. & Marrelli, M. T. Paratransgenesis: a promising new strategy for mosquito vector control. Parasit. Vectors 8, 342 (2015).
  PubMed PubMed Central Google Scholar
• Wang, S. et al. Fighting malaria with engineered symbiotic bacteria from vector mosquitoes. Proc. Natl Acad. Sci. USA 109, 12734–12739 (2012).
  CAS PubMed PubMed Central Google Scholar
• Lee, S. J., Ter Kuile, F. O., Price, R. N., Luxemburger, C. & Nosten, F. Adverse effects of mefloquine for the treatment of uncomplicated malaria in Thailand: a pooled analysis of 19, 850 individual patients. PLoS ONE 12, e0168780 (2017).
  PubMed PubMed Central Google Scholar
• Spinner, C. D. et al. HIV pre-exposure prophylaxis (PrEP): a review of current knowledge of oral systemic HIV PrEP in humans. Infection 44, 151–158 (2016).
  PubMed Google Scholar
• Margolis, D. A. & Boffito, M. Long-acting antiviral agents for HIV treatment. Curr. Opin. HIV AIDS 10, 246–252 (2015).
  CAS PubMed PubMed Central Google Scholar
• World Health Organization. WHO policy recommendation: seasonal malaria chemoprevention (SMC) for Plasmodium falciparum malaria control in highly seasonal transmission areas of the Sahel sub-region in Africa. WHOhttp://www.who.int/malaria/publications/atoz/who_smc_policy_recommendation/en/ (2012).
• Cairns, M. et al. Estimating the potential public health impact of seasonal malaria chemoprevention in African children. Nat. Commun. 3, 881 (2012).
  PubMed Google Scholar
• Noor, A. M. et al. Sub-national targeting of seasonal malaria chemoprevention in the Sahelian countries of the Nouakchott initiative. PLoS ONE 10, e0136919 (2015).
  PubMed PubMed Central Google Scholar
• Tagbor, H. et al. Seasonal malaria chemoprevention in an area of extended seasonal transmission in Ashanti, Ghana: an individually randomised clinical trial. Trop. Med. Int. Health 21, 224–235 (2016).
  PubMed Google Scholar
• Tine, R. C. et al. Feasibility, safety and effectiveness of combining home based malaria management and seasonal malaria chemoprevention in children less than 10 years in Senegal: a cluster-randomised trial. Trans. R. Soc. Trop. Med. Hyg. 108, 13–21 (2014).
  CAS PubMed Google Scholar
• Zongo, I. et al. Randomized noninferiority trial of dihydroartemisinin–piperaquine compared with sulfadoxine–pyrimethamine plus amodiaquine for seasonal malaria chemoprevention in Burkina Faso. Antimicrob. Agents Chemother. 59, 4387–4396 (2015).
  CAS PubMed PubMed Central Google Scholar
• Wilson, A. L. & IPTc Taskforce. A systematic review and meta-analysis of the efficacy and safety of intermittent preventive treatment of malaria in children (IPTc). PLoS ONE 6, e16976 (2011).
  CAS PubMed PubMed Central Google Scholar
• Matondo, S. I. et al. High levels of sulphadoxine–pyrimethamine resistance Pfdhfr_–_Pfdhps quintuple mutations: a cross sectional survey of six regions in Tanzania. Malar. J. 13, 152 (2014).
  PubMed PubMed Central Google Scholar
• Gutman, J., Kovacs, S., Dorsey, G., Stergachis, A. & Ter Kuile, F. O. Safety, tolerability, and efficacy of repeated doses of dihydroartemisinin–piperaquine for prevention and treatment of malaria: a systematic review and meta-analysis. Lancet Infect. Dis. 17, 184–193 (2017).
  CAS PubMed PubMed Central Google Scholar
• Doolan, D. L., Dobano, C. & Baird, J. K. Acquired immunity to malaria. Clin. Microbiol. Rev. 22, 13–36 (2009).
  CAS PubMed PubMed Central Google Scholar
• Hoffman, S. L., Vekemans, J., Richie, T. L. & Duffy, P. E. The march toward malaria vaccines. Am. J. Prev. Med. 49, S319–S333 (2015).
  PubMed PubMed Central Google Scholar
• Keegan, L. T. & Dushoff, J. Population-level effects of clinical immunity to malaria. BMC Infect. Dis. 13, 428 (2013).
  PubMed PubMed Central Google Scholar
• McCarthy, J. S. et al. Experimentally induced blood-stage Plasmodium vivax infection in healthy volunteers. J. Infect. Dis. 208, 1688–1694 (2013).
  CAS PubMed PubMed Central Google Scholar
• Roestenberg, M. et al. Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study. Lancet 377, 1770–1776 (2011).
  CAS PubMed Google Scholar
• Engwerda, C. R., Minigo, G., Amante, F. H. & McCarthy, J. S. Experimentally induced blood stage malaria infection as a tool for clinical research. Trends Parasitol. 28, 515–521 (2012).
  PubMed Google Scholar
• Wykes, M. N., Horne-Debets, J. M., Leow, C. Y. & Karunarathne, D. S. Malaria drives T cells to exhaustion. Front. Microbiol. 5, 249 (2014).
  PubMed PubMed Central Google Scholar
• RTS,S Clinical Trials Partnership. Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. Lancet 386, 31–45 (2015). Describes a key clinical study that evaluates the efficacy of the only malaria vaccine that is currently at an advanced stage of clinical development.
  Google Scholar
• Penny, M. A. et al. Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models. Lancet 387, 367–375 (2015).
  PubMed Google Scholar
• Gosling, R. & von Seidlein, L. The future of the RTS, S/AS01 malaria vaccine: an alternative development plan. PLoS Med. 13, e1001994 (2016). Describes strategies for effectively integrating the RTS,S/AS01 vaccine into malaria control strategies.
  PubMed PubMed Central Google Scholar
• Hoffman, S. L. et al. Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J. Infect. Dis. 185, 1155–1164 (2002).
  PubMed Google Scholar
• Draper, S. J. et al. Recent advances in recombinant protein-based malaria vaccines. Vaccine 33, 7433–7443 (2015).
  CAS PubMed PubMed Central Google Scholar
• World Health Organization. WHO Product Development for Vaccines Advisory Committee (PD-VAC) meeting — 2015. WHOhttp://www.who.int/immunization/research/meetings_workshops/pdvac/en/ (2015).
• Nunes, J. K. et al. Development of a transmission-blocking malaria vaccine: progress, challenges, and the path forward. Vaccine 32, 5531–5539 (2014).
  PubMed Google Scholar
• Shimp, R. L. Jr et al. Development of a Pfs25–EPA malaria transmission blocking vaccine as a chemically conjugated nanoparticle. Vaccine 31, 2954–2962 (2013).
  CAS PubMed PubMed Central Google Scholar
• Kelley, B. Industrialization of mAb production technology: the bioprocessing industry at a crossroads. mAbs 1, 443–452 (2009).
  PubMed PubMed Central Google Scholar
• Robbie, G. J. et al. A novel investigational Fc-modified humanized monoclonal antibody, motavizumab-YTE, has an extended half-life in healthy adults. Antimicrob. Agents Chemother. 57, 6147–6153 (2013).
  CAS PubMed PubMed Central Google Scholar
• US National Library of Medicine. ClinicalTrials.govhttps://clinicaltrials.gov/ct2/show/NCT01939899 (2017).
• US National Library of Medicine. ClinicalTrials.govhttps://clinicaltrials.gov/ct2/show/NCT02647489 (2016).
• Daily, J. P. Malaria 2017: update on the clinical literature and management. _Curr. Infect. Dis. Rep._http://dx.doi.org/10.1007/s11908-017-0583-8 (2017).
• Harrison, N. In celebration of the Jesuit's powder: a history of malaria treatment. Lancet Infect. Dis. 15, 1143 (2015).
  Google Scholar
• Kinfu, G., Gebre-Selassie, S. & Fikrie, N. Therapeutic efficacy of artemether–lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in northern Ethiopia. Malar. Res. Treat. 2012, 548710 (2012).
  PubMed PubMed Central Google Scholar
• Sinclair, D., Donegan, S., Isba, R. & Lalloo, D. G. Artesunate versus quinine for treating severe malaria. Cochrane Database Syst. Rev. 6, CD005967 (2012).
  Google Scholar
• Dondorp, A. et al. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet 366, 717–725 (2005). Describes a key study that demonstrates the efficacy of artesunate for the treatment of malaria and, therefore, supports the clinical use of artesunate.
  PubMed Google Scholar
• Dondorp, A. M. et al. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet 376, 1647–1657 (2010).
  CAS PubMed PubMed Central Google Scholar
• Okebe, J. & Eisenhut, M. Pre-referral rectal artesunate for severe malaria. Cochrane Database Syst. Rev. 5, CD009964 (2014).
  Google Scholar
• Verhave, J. P. Experimental, therapeutic and natural transmission of Plasmodium vivax tertian malaria: scientific and anecdotal data on the history of Dutch malaria studies. Parasit. Vectors 6, 19 (2013).
  PubMed PubMed Central Google Scholar
• Llanos-Cuentas, A. et al. Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study. Lancet 383, 1049–1058 (2014). Describes a key clinical study that demonstrates the efficacy of the only new compound that can prevent P. vivax relapse; tafenoquine and primaquine are the only compounds that have such activity.
  CAS PubMed Google Scholar
• White, N. J. Does antimalarial mass drug administration increase or decrease the risk of resistance? Lancet Infect. Dis. 17, e15–e20 (2017).
  PubMed Google Scholar
• Amato, R. et al. Genetic markers associated with dihydroartemisinin–piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype–phenotype association study. Lancet Infect. Dis. 17, 164–173 (2017).
  CAS PubMed Google Scholar
• Ariey, F. et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature 505, 50–55 (2014).
  PubMed Google Scholar
• World Health Organization. World malaria report 2016. WHOhttp://www.who.int/malaria/publications/world-malaria-report-2016/report/en/ (2016).
• Lu, F. et al. Emergence of indigenous artemisinin-resistant Plasmodium falciparum in Africa. N. Engl. J. Med. 376, 991–993 (2017).
  Google Scholar
• Sutherland, C. J. et al. _Pfk13_-independent treatment failure in four imported cases of Plasmodium falciparum malaria treated with artemether–lumefantrine in the United Kingdom. Antimicrob. Agents Chemother. 61 e02382-16 (2017).
  PubMed PubMed Central Google Scholar
• Lukens, A. K. et al. Harnessing evolutionary fitness in Plasmodium falciparum for drug discovery and suppressing resistance. Proc. Natl Acad. Sci. USA 111, 799–804 (2014).
  CAS PubMed Google Scholar
• Taylor, A. R. et al. Artemether–lumefantrine and dihydroartemisinin–piperaquine exert inverse selective pressure on Plasmodium falciparum drug sensitivity-associated haplotypes in Uganda. Open Forum Infect. Dis. 4, ofw229 (2017).
  PubMed Google Scholar
• Gamo, F. J. et al. Thousands of chemical starting points for antimalarial lead identification. Nature 465, 305–310 (2010).
  CAS PubMed Google Scholar
• Möhrle, J. J. et al. First-in-man safety and pharmacokinetics of synthetic ozonide OZ439 demonstrates an improved exposure profile relative to other peroxide antimalarials. Br. J. Clin. Pharmacol. 75, 524–537 (2013).
  Google Scholar
• Phyo, A. P. et al. Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial. Lancet Infect. Dis. 16, 61–69 (2016). Describes the key phase II clinical study of one of only two new clinical candidates that have reached phase IIb clinical development.
  CAS PubMed PubMed Central Google Scholar
• McCarthy, J. S. et al. A phase II pilot trial to evaluate safety and efficacy of ferroquine against early Plasmodium falciparum in an induced blood-stage malaria infection study. Malar. J. 15 469 (2016).
  PubMed PubMed Central Google Scholar
• Held, J. et al. Ferroquine and artesunate in African adults and children with Plasmodium falciparum malaria: a phase 2, multicentre, randomised, double-blind, dose-ranging, non-inferiority study. Lancet Infect. Dis. 15, 1409–1419 (2015).
  CAS PubMed Google Scholar
• Leong, F. J. et al. A first-in-human randomized, double-blind, placebo-controlled, single- and multiple-ascending oral dose study of novel imidazolopiperazine KAF156 to assess its safety, tolerability, and pharmacokinetics in healthy adult volunteers. Antimicrob. Agents Chemother. 58, 6437–6443 (2014).
  PubMed PubMed Central Google Scholar
• White, N. J. et al. Antimalarial activity of KAF156 in falciparum and vivax malaria. N. Engl. J. Med. 375, 1152–1160 (2016).
  CAS PubMed PubMed Central Google Scholar
• Kuhen, K. L. et al. KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment and prevention of disease transmission. Antimicrob. Agents Chemother. 58, 5060–5067 (2014).
  PubMed PubMed Central Google Scholar
• Huskey, S. E. et al. KAE609 (Cipargamin), a new spiroindolone agent for the treatment of malaria: evaluation of the absorption, distribution, metabolism, and excretion of a single oral 300- mg dose of [14C]KAE609 in healthy male subjects. Drug Metab. Dispos. 44, 672–682 (2016).
  CAS PubMed Google Scholar
• White, N. J. et al. Spiroindolone KAE609 for falciparum and vivax malaria. N. Engl. J. Med. 371, 403–410 (2014).
  PubMed PubMed Central Google Scholar
• McCarthy, J. S. et al. Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised study. Lancet Infect. Dis. 17, 626–635 (2017). References 184 and 185 describe key clinical studies that support the efficacy of new antimalarials in the clinical development portfolio.
  CAS PubMed PubMed Central Google Scholar
• Phillips, M. A. et al. A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria. Sci. Transl Med. 7, 296ra111 (2015). Describes the biological activity and product profile of the first inhibitor of PfDHODH to reach clinical development.
  PubMed PubMed Central Google Scholar
• Rüeckle, T. et al. A phase IIa proof-of-concept study to assess the efficacy, safety, tolerability and pharmacokinetics of single doses of DSM265 in adult patients with acute, uncomplicated Plasmodium falciparum or vivax malaria mono-infection over a 28-day-extended observation period in Iquitos, Peru. ASTMHhttp://www.abstractsonline.com/Plan/ViewAbstract.aspx?sKey=2e5199c4-aceb-4d61-8769-342586917c5a&cKey=d7fda50e-36c6-4a28-a76b-96bad2ec308b&mKey=%7bAB652FDF-0111-45C7-A5E5-0BA9D4AF5E12%7d (2015).
• Sulyok, M. et al. DSM265 for Plasmodium falciparum chemoprophylaxis: a randomised, double blinded, phase 1 trial with controlled human malaria infection. Lancet Infect. Dis. 17, 636–644 (2017). Describes the first use of a sporozoite human challenge study to demonstrate the chemopreventive activity of a compound that is under clinical development.
  CAS PubMed PubMed Central Google Scholar
• Das, S. et al. Na+ influx induced by new antimalarials causes rapid alterations in the cholesterol content and morphology of Plasmodium falciparum . PLoS Pathog. 12, e1005647 (2016).
  PubMed PubMed Central Google Scholar
• Coteron, J. M. et al. Structure-guided lead optimization of triazolopyrimidine-ring substituents identifies potent Plasmodium falciparum dihydroorotate dehydrogenase inhibitors with clinical candidate potential. J. Med. Chem. 54, 5540–5561 (2011).
  CAS PubMed PubMed Central Google Scholar
• Ghidelli-Disse, S. et al. Identification of Plasmodium PI4 kinase as target of MMV390048 by chemoproteomics. Malar. J. 13, S21 (2014).
  Google Scholar
• Paquet, T. et al. Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase. Sci. Transl Med. 9 eaad9735 (2017).
  PubMed PubMed Central Google Scholar
• Ge, J. F. et al. Discovery of novel benzo[_a_]phenoxazine SSJ-183 as a drug candidate for malaria. ACS Med. Chem. Lett. 1, 360–364 (2010).
  CAS PubMed PubMed Central Google Scholar
• Abbat, S., Jain, V. & Bharatam, P. V. Origins of the specificity of inhibitor P218 toward wild-type and mutant PfDHFR: a molecular dynamics analysis. J. Biomol. Struct. Dyn. 33, 1913–1928 (2015).
  CAS PubMed Google Scholar
• Wells, T. N. C., Hooft van Huijsduijnen, R. & Van Voorhis, W. C. Malaria medicines: a glass half full? Nat. Rev. Drug Discov. 14, 424–442 (2015). Comprehensively reviews the malaria drug discovery pipeline.
  CAS PubMed Google Scholar
• Das, S. et al. Rapid reorganization of the parasite plasma membrane in response to a new class of antimalarial drugs. ISMMIDhttp://immid-is.drexelmed.edu/2014_ISMMID_Abstract.pdf (2014).
• Phillips, M. A. et al. A triazolopyrimidine-based dihydroorotate dehydrogenase inhibitor with improved drug-like properties for treatment and prevention of malaria. ACS Infect. Dis. 2, 945–957 (2016).
  CAS PubMed PubMed Central Google Scholar
• Le Manach, C. et al. Identification of a potential antimalarial drug candidate from a series of 2-aminopyrazines by optimization of aqueous solubility and potency across the parasite life cycle. J. Med. Chem. 59, 9890–9905 (2016).
  CAS PubMed Google Scholar
• Baragaña, B. et al. A novel multiple-stage antimalarial agent that inhibits protein synthesis. Nature 522, 315–320 (2015).
  PubMed PubMed Central Google Scholar
• Hameed, P. S. et al. Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidate. Nat. Commun. 6, 6715 (2015).
  Google Scholar
• Zhang, Y. K. et al. Synthesis and structure–activity relationships of novel benzoxaboroles as a new class of antimalarial agents. Bioorg. Med. Chem. Lett. 21, 644–651 (2011).
  CAS PubMed Google Scholar
• Chavchich, M. et al. Lead selection of the new aminomethylphenol, JPC-3210 for malaria treatment and prevention. Antimicrob. Agents Chemother. 60, 3115–3118 (2016).
  CAS PubMed PubMed Central Google Scholar
• Basch, P. Textbook of International Health 2nd edn (Oxford Univ. Press, 1999).
  Google Scholar
• Ouattara, A. F. et al. Malaria knowledge and long-lasting insecticidal net use in rural communities of central Cote d’Ivoire. Malar. J. 10, 288 (2011).
  PubMed PubMed Central Google Scholar
• Adetokunbo, O. & Gilles, H. Short Textbook of Public Health, Medicine for the Tropics (BookPower, 2006).
  Google Scholar
• Carter, J. A. et al. Persistent neurocognitive impairments associated with severe falciparum malaria in Kenyan children. J. Neurol. Neurosurg. Psychiatry 76, 476–481 (2005).
  CAS PubMed PubMed Central Google Scholar
• Fernando, S. D., Rodrigo, C. & Rajapakse, S. The ‘hidden’ burden of malaria: cognitive impairment following infection. Malar. J. 9, 366 (2010).
  PubMed PubMed Central Google Scholar
• Kihara, M., Carter, J. A. & Newton, C. R. The effect of Plasmodium falciparum on cognition: a systematic review. Trop. Med. Int. Health 11, 386–397 (2006).
  PubMed Google Scholar
• Holding, P. A. & Snow, R. W. Impact of Plasmodium falciparum malaria on performance and learning: review of the evidence. Am. J. Trop. Med. Hyg. 64, 68–75 (2001).
  CAS PubMed Google Scholar
• World Health Organization. Global technical strategy for Malaria 2016–2030. WHOhttp://who.int/malaria/areas/global_technical_strategy/en/ (2016).
• Noedl, H. et al. Evidence of artemisinin-resistant malaria in western Cambodia. N. Engl. J. Med. 359, 2619–2620 (2008).
  CAS PubMed Google Scholar
• Singh, R. et al. Comparison of three PCR-based assays for the non-invasive diagnosis of malaria: detection of Plasmodium parasites in blood and saliva. Eur. J. Clin. Microbiol. Infect. Dis. 33, 1631–1639 (2014).
  CAS PubMed Google Scholar
• Oguonu, T. et al. The performance evaluation of a urine malaria test (UMT) kit for the diagnosis of malaria in individuals with fever in South-east Nigeria: cross-sectional analytical study. Malar. J. 13, 403 (2014).
  PubMed PubMed Central Google Scholar
• Berna, A. Z. et al. Analysis of breath specimens for biomarkers of Plasmodium falciparum infection. J. Infect. Dis. 212, 1120–1128 (2015).
  CAS PubMed PubMed Central Google Scholar
• Lukianova-Hleb, E. et al. Transdermal diagnosis of malaria using vapor nanobubbles. Emerg. Infect. Dis. 21, 1122–1127 (2015).
  CAS PubMed PubMed Central Google Scholar
• World Health Organization. Emergency response to artemisinin resistance in the greater Mekong subregion. Regional framework for action 2013–2015. WHOhttp://www.who.int/malaria/publications/atoz/9789241505321/en/ (2013).
• Rao, P. N. et al. A method for amplicon deep sequencing of drug resistance genes in Plasmodium falciparum clinical isolates from India. J. Clin. Microbiol. 54, 1500–1511 (2016).
  CAS PubMed PubMed Central Google Scholar
• Wells, T. N., Burrows, J. N. & Baird, J. K. Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination. Trends Parasitol. 26, 145–151 (2010). Discusses issues related to targeting the latent stages of P. vivax to address the lack of drug options that are safe in all patients to treat these stages of the parasite.
  PubMed Google Scholar
• Chattopadhyay, R. et al. Establishment of an in vitro assay for assessing the effects of drugs on the liver stages of Plasmodium vivax malaria. PLoS ONE 5, e14275 (2010).
  PubMed PubMed Central Google Scholar
• Burrows, J. N., Hooft van Huijsduijnen, R., Möhrle, J. J., Oeuvray, C. & Wells, T. N. C. Designing the next generation of medicines for malaria control and eradication. Malar. J. 12, 187 (2013). Defines TCPs and Target Product Profiles for malaria.
  PubMed PubMed Central Google Scholar
• Burrows, J. N. et al. New developments in anti-malarial target candidate and product profiles. Malar. J. 16, 26 (2017). Comprehensively analyses the compound properties that are required for the development of effective antimalarials that will cover all species and stages of the disease.
  PubMed PubMed Central Google Scholar
• Tate, E. W., Bell, A. S., Rackham, M. D. & Wright, M. H. _N_-Myristoyltransferase as a potential drug target in malaria and leishmaniasis. Parasitology 141, 37–49 (2014).
  CAS PubMed Google Scholar
• Pett, H. E. et al. Novel pantothenate derivatives for anti-malarial chemotherapy. Malar. J. 14, 169 (2015).
  PubMed PubMed Central Google Scholar
• Kato, N. et al. Diversity-oriented synthesis yields novel multistage antimalarial inhibitors. Nature 538, 344–349 (2016).
  CAS PubMed PubMed Central Google Scholar
• Herman, J. D. et al. The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogs. Sci. Transl Med. 7, 288ra277 (2015).
  Google Scholar
• Russo, I. et al. Plasmepsin V licenses Plasmodium proteins for export into the host erythrocyte. Nature 463, 632–636 (2010).
  CAS PubMed PubMed Central Google Scholar
• Nilsen, A. et al. Quinolone-3-diarylethers: a new class of antimalarial drug. Sci. Transl Med. 5, 177ra137 (2013).
  Google Scholar
• Newton, C. R., Taylor, T. E. & Whitten, R. O. Pathophysiology of fatal falciparum malaria in African children. Am. J. Trop. Med. Hyg. 58, 673–683 (1998).
  CAS PubMed Google Scholar
• Kalanon, M. & McFadden, G. I. Malaria. Plasmodium falciparum and its apicoplast. Biochem. Soc. Trans. 38, 775–782 (2010). Describes the importance of the apicoplast genome to the malaria parasite and opportunities to target this unique organelle for drug discovery.
  CAS PubMed Google Scholar
• Bozdech, Z. et al. The transcriptome of the intraerythrocytic developmental cycle of Plasmodium falciparum . PLoS Biol. 1, E5 (2003).
  PubMed PubMed Central Google Scholar
• Hughes, K. R., Philip, N., Starnes, G. L., Taylor, S. & Waters, A. P. From cradle to grave: RNA biology in malaria parasites. Wiley Interdiscip. Rev. RNA 1, 287–303 (2010).
  CAS PubMed Google Scholar
• Llinas, M., Bozdech, Z., Wong, E. D., Adai, A. T. & DeRisi, J. L. Comparative whole genome transcriptome analysis of three Plasmodium falciparum strains. Nucleic Acids Res. 34, 1166–1173 (2006).
  CAS PubMed PubMed Central Google Scholar
• Ganesan, K. et al. A genetically hard-wired metabolic transcriptome in Plasmodium falciparum fails to mount protective responses to lethal antifolates. PLoS Pathog. 4, e1000214 (2008).
  PubMed PubMed Central Google Scholar
• Hu, G. et al. Transcriptional profiling of growth perturbations of the human malaria parasite Plasmodium falciparum . Nat. Biotechnol. 28, 91–98 (2010).
  CAS PubMed Google Scholar
• Hoo, R. et al. Integrated analysis of the Plasmodium species transcriptome. EBioMedicine 7, 255–266 (2016).
  PubMed PubMed Central Google Scholar
• Caro, F., Ahyong, V., Betegon, M. & DeRisi, J. L. Genome-wide regulatory dynamics of translation in the Plasmodium falciparum asexual blood stages. eLife 3, e04106 (2014). Describes a comprehensive analysis of the P. falciparum transcriptome over the red blood cell cycle.
  PubMed Central Google Scholar
• Kirchner, S., Power, B. J. & Waters, A. P. Recent advances in malaria genomics and epigenomics. Genome Med. 8, 92 (2016). Comprehensively reviews of the role of epigenomics in gene expression in Plasmodium spp.
  PubMed PubMed Central Google Scholar
• Lee, M. C. & Fidock, D. A. CRISPR-mediated genome editing of Plasmodium falciparum malaria parasites. Genome Med. 6, 63 (2014). Reviews genetic approaches to manipulating the P. falciparum genome.
  PubMed PubMed Central Google Scholar
• de Koning-Ward, T. F., Gilson, P. R. & Crabb, B. S. Advances in molecular genetic systems in malaria. Nat. Rev. Microbiol. 13, 373–387 (2015). Reviews genetic approaches to manipulating the Plasmodium spp. genome.
  CAS PubMed Google Scholar
• Gomes, A. R. et al. A genome-scale vector resource enables high-throughput reverse genetic screening in a malaria parasite. Cell Host Microbe 17, 404–413 (2015).
  CAS PubMed PubMed Central Google Scholar
• Corey, V. C. et al. A broad analysis of resistance development in the malaria parasite. Nat. Commun. 7, 11901 (2016).
  CAS PubMed PubMed Central Google Scholar
• Allman, E. L., Painter, H. J., Samra, J., Carrasquilla, M. & Llinas, M. Metabolomic profiling of the malaria box reveals antimalarial target pathways. Antimicrob. Agents Chemother. 60, 6635–6649 (2016).
  CAS PubMed PubMed Central Google Scholar
• Manyando, C. et al. Safety of artemether–lumefantrine in pregnant women with malaria: results of a prospective cohort study in Zambia. Malar. J. 9, 249 (2010).
  PubMed PubMed Central Google Scholar
• Yanow, S. K., Gavina, K., Gnidehou, S. & Maestre, A. Impact of malaria in pregnancy as Latin America approaches elimination. Trends Parasitol. 32, 416–427 (2016).
  PubMed Google Scholar
• Harrington, W. E., Morrison, R., Fried, M. & Duffy, P. E. Intermittent preventive treatment in pregnant women is associated with increased risk of severe malaria in their offspring. PLoS ONE 8, e56183 (2013).
  CAS PubMed PubMed Central Google Scholar
• Dellicour, S. et al. First-trimester artemisinin derivatives and quinine treatments and the risk of adverse pregnancy outcomes in Africa and Asia: a meta-analysis of observational studies. PLoS Med. 14, e1002290 (2017).
  PubMed PubMed Central Google Scholar
• Van Voorhis, W. C., Hooft van Huijsduijnen, R. & Wells, T. N. C. Profile of William C. Campbell, Satoshi O®mura, and Youyou Tu, 2015 Nobel Laureates in Physiology or Medicine. Proc. Natl Acad. Sci. USA 112, 15773–15776 (2015).
  CAS PubMed PubMed Central Google Scholar
• White, N. J., Hien, T. T. & Nosten, F. H. A. Brief history of qinghaosu. Trends Parasitol. 31, 607–610 (2015). Reviews the history of the discovery of artemisinin derivatives.
  PubMed PubMed Central Google Scholar
• White, N. J. et al. Averting a malaria disaster. Lancet 353, 1965–1967 (1999).
  CAS PubMed Google Scholar
• White, N. J. & Olliaro, P. L. Strategies for the prevention of antimalarial drug resistance: rationale for combination chemotherapy for malaria. Parasitol. Today 12, 399–401 (1996).
  CAS PubMed Google Scholar
• Hien, T. T. & White, N. J. Qinghaosu. Lancet 341, 603–608 (1993).
  CAS PubMed Google Scholar
• Vaid, A., Ranjan, R., Smythe, W. A., Hoppe, H. C. & Sharma, P. PfPI3K, a phosphatidylinositol-3 kinase from Plasmodium falciparum, is exported to the host erythrocyte and is involved in hemoglobin trafficking. Blood 115, 2500–2507 (2010).
  CAS PubMed PubMed Central Google Scholar
• Mbengue, A. et al. A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria. Nature 520, 683–687 (2015).
  CAS PubMed PubMed Central Google Scholar
• Annan, Z. et al. Population genetic structure of Plasmodium falciparum in the two main African vectors. Anopheles gambiae and Anopheles funestus. Proc. Natl Acad. Sci. USA 104, 7987–7992 (2007).
  PubMed PubMed Central Google Scholar
• Josling, G. A. & Llinas, M. Sexual development in Plasmodium parasites: knowing when it's time to commit. Nat. Rev. Microbiol. 13, 573–587 (2015).
  CAS PubMed Google Scholar
• Aly, A. S., Vaughan, A. M. & Kappe, S. H. Malaria parasite development in the mosquito and infection of the mammalian host. Annu. Rev. Microbiol. 63, 195–221 (2009).
  CAS PubMed PubMed Central Google Scholar
• World Health Organization. Climate change and human health. WHOhttp://www.who.int/globalchange/summary/en/index5.html (2017).
• Gething, P. W. et al. Modelling the global constraints of temperature on transmission of Plasmodium falciparum and P. vivax. Parasit. Vectors 4, 92 (2011).
  PubMed PubMed Central Google Scholar
• Weiss, G. E. et al. Revealing the sequence and resulting cellular morphology of receptor–ligand interactions during Plasmodium falciparum invasion of erythrocytes. PLoS Pathog. 11, e1004670 (2015).
  CAS PubMed PubMed Central Google Scholar
• Egan, E. S. et al. Malaria. A forward genetic screen identifies erythrocyte CD55 as essential for Plasmodium falciparum invasion. Science 348, 711–714 (2015).
  CAS PubMed PubMed Central Google Scholar
• Crosnier, C. et al. Basigin is a receptor essential for erythrocyte invasion by Plasmodium falciparum . Nature 480, 534–537 (2011). References 260 and 261 identify key receptors involved in P. falciparum invasion.
  CAS PubMed PubMed Central Google Scholar
• Volz, J. C. et al. Essential role of the PfRh5/PfRipr/CyRPA complex during Plasmodium falciparum invasion of erythrocytes. Cell Host Microbe 20, 60–71 (2016). Provides a comprehensive molecular understanding of the role of the receptor basigin in P. falciparum invasion and provides a comprehensive molecular model for the invasion process that highlights the three key steps.
  CAS PubMed Google Scholar
• Zenonos, Z. A. et al. Basigin is a druggable target for host-oriented antimalarial interventions. J. Exp. Med. 212, 1145–1151 (2015).
  CAS PubMed PubMed Central Google Scholar
• Srinivasan, P. et al. Binding of Plasmodium merozoite proteins RON2 and AMA1 triggers commitment to invasion. Proc. Natl Acad. Sci. USA 108, 13275–13280 (2011).
  CAS PubMed PubMed Central Google Scholar
• Remarque, E. J., Faber, B. W., Kocken, C. H. & Thomas, A. W. Apical membrane antigen 1: a malaria vaccine candidate in review. Trends Parasitol. 24, 74–84 (2008).
  CAS PubMed Google Scholar
• Yuthavong, Y. et al. Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target. Proc. Natl Acad. Sci. USA 109, 16823–16828 (2012).
  CAS PubMed PubMed Central Google Scholar
• Sidhu, A. B., Verdier-Pinard, D. & Fidock, D. A. Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations. Science 298, 210–213 (2002). Describes the identification of the molecular basis for chloroquine resistance.
  CAS PubMed PubMed Central Google Scholar
• Lek-Uthai, U. et al. Stronger activity of human immunodeficiency virus type 1 protease inhibitors against clinical isolates of Plasmodium vivax than against those of P. falciparum. Antimicrob. Agents Chemother. 52, 2435–2441 (2008).
  CAS PubMed PubMed Central Google Scholar
• World Health Organization. Rainbow tables. WHOhttp://www.who.int/immunization/research/development/Rainbow_tables/en/ (2017).
• Mishra, N. et al. Emerging polymorphisms in falciparum Kelch 13 gene in northeastern region of India. Malar. J. 15, 583 (2016).
  PubMed PubMed Central Google Scholar
• Spring, M. D. et al. Dihydroartemisinin–piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study. Lancet Infect. Dis. 15, 683–691 (2015).
  CAS PubMed Google Scholar
• Thuy-Nhien, N. et al. K13-propeller mutations in Plasmodium falciparum populations in malaria endemic regions of Vietnam from 2009 to 2016. Antimicrob. Agents Chemother. 61, e01578-16 (2017).
  PubMed PubMed Central Google Scholar
• Thanh, N. V. et al. Rapid decline in the susceptibility of Plasmodium falciparum to dihydroartemisinin–piperaquine in the south of Vietnam. Malar. J. 16, 27 (2017).
  PubMed PubMed Central Google Scholar
• Sanchez, C. P. et al. Evidence for a _pfcrt_-associated chloroquine efflux system in the human malarial parasite Plasmodium falciparum . Biochemistry 44, 9862–9870 (2005).
  CAS PubMed Google Scholar
• Valderramos, S. G. & Fidock, D. A. Transporters involved in resistance to antimalarial drugs. Trends Pharmacol. Sci. 27, 594–601 (2006). Comprehensively reviews transporter mutants that are involved in resistance to the aminoquinoline series of antimalarial drugs (for example, chloroquine).
  CAS PubMed PubMed Central Google Scholar
• Borges, S. et al. Genomewide scan reveals amplification of mdr1 as a common denominator of resistance to mefloquine, lumefantrine, and artemisinin in Plasmodium chabaudi malaria parasites. Antimicrob. Agents Chemother. 55, 4858–4865 (2011).
  CAS PubMed PubMed Central Google Scholar
• Humphreys, G. S. et al. Amodiaquine and artemether–lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria. Antimicrob. Agents Chemother. 51, 991–997 (2007).
  CAS PubMed Google Scholar
• Baliraine, F. N. & Rosenthal, P. J. Prolonged selection of pfmdr1 polymorphisms after treatment of falciparum malaria with artemether–lumefantrine in Uganda. J. Infect. Dis. 204, 1120–1124 (2011).
  CAS PubMed PubMed Central Google Scholar
• Martin, R. E. & Kirk, K. The malaria parasite's chloroquine resistance transporter is a member of the drug/metabolite transporter superfamily. Mol. Biol. Evol. 21, 1938–1949 (2004).
  CAS PubMed Google Scholar
• Ehrhardt, S. et al. Large-scale surveillance of Plasmodium falciparum crt(K76T) in northern Ghana. Antimicrob. Agents Chemother. 51, 3407–3409 (2007).
  CAS PubMed PubMed Central Google Scholar
• Figueiredo, P. et al. Prevalence of pfmdr1, pfcrt, pfdhfr and pfdhps mutations associated with drug resistance, in Luanda, Angola. Malar. J. 7, 236 (2008).
  PubMed PubMed Central Google Scholar
• Mens, P. F. Ambiguous role of pfcrt K76 in Plasmodium falciparum: a marker of resistance or increased susceptibility. Expert Rev. Anti Infect. Ther. 7, 409–412 (2009).
  CAS PubMed Google Scholar
• Restrepo-Pineda, E., Arango, E., Maestre, A., Rosário, V. E. D. & Cravo, P. Studies on antimalarial drug susceptibility in Colombia, in relation to Pfmdr1 and Pfcrt. Parasitology 135, 547–553 (2008).
  CAS PubMed Google Scholar
• Drew, M. E. et al. Plasmodium food vacuole plasmepsins are activated by falcipains. J. Biol. Chem. 283, 12870–12876 (2008).
  CAS PubMed PubMed Central Google Scholar
• Witkowski, B. et al. A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype–genotype association study. Lancet Infect. Dis. 17, 174–183 (2017).
  CAS PubMed PubMed Central Google Scholar